These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice. Derosa G; Sahebkar A; Maffioli P J Cell Physiol; 2018 Jan; 233(1):153-161. PubMed ID: 28098353 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. Nadanaciva S; Dykens JA; Bernal A; Capaldi RA; Will Y Toxicol Appl Pharmacol; 2007 Sep; 223(3):277-87. PubMed ID: 17658574 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines. Atarod EB; Kehrer JP Free Radic Biol Med; 2004 Jul; 37(1):36-47. PubMed ID: 15183193 [TBL] [Abstract][Full Text] [Related]
12. Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? Scatena R; Bottoni P; Giardina B PPAR Res; 2008; 2008():256251. PubMed ID: 18645611 [TBL] [Abstract][Full Text] [Related]
13. A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. Bottoni P; Giardina B; Martorana GE; Zuppi C; De Sole P; Rossi C; Scatena R J Cell Mol Med; 2005; 9(2):462-7. PubMed ID: 15963265 [TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones as antidiabetic agents: A critical review. Nanjan MJ; Mohammed M; Prashantha Kumar BR; Chandrasekar MJN Bioorg Chem; 2018 Apr; 77():548-567. PubMed ID: 29475164 [TBL] [Abstract][Full Text] [Related]
15. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. Ibabe A; Herrero A; Cajaraville MP Toxicol In Vitro; 2005 Sep; 19(6):725-35. PubMed ID: 15964169 [TBL] [Abstract][Full Text] [Related]
17. Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Scatena R; Bottoni P; Vincenzoni F; Messana I; Martorana GE; Nocca G; De Sole P; Maggiano N; Castagnola M; Giardina B Chem Res Toxicol; 2003 Nov; 16(11):1440-7. PubMed ID: 14615970 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Patsouris D; Müller M; Kersten S Curr Opin Investig Drugs; 2004 Oct; 5(10):1045-50. PubMed ID: 15535425 [TBL] [Abstract][Full Text] [Related]
19. PPAR agonists modulate human osteoclast formation and activity in vitro. Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686 [TBL] [Abstract][Full Text] [Related]
20. [Nuclear receptors PPAR as a drug target in metabolic disorders]. Stolarczyk M; Gutman W; Derlacz RA Postepy Biochem; 2011; 57(2):207-14. PubMed ID: 21913422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]